
Clyde Biosciences is the leading cardiac cell analysis solution provider, used by the biopharma industry to help bring better, safer drugs to market. Our services are conducted on the CellOPTIQ® platform, a unique technology designed to eliminate the risk of false positive or false negative results. CellOPTIQ® provides clients with unparalleled data at a time when the industry needs it most, offering greater data resolution than any other assay, doing so in one experiment. With over 100 years of combined electrophysiology and computational experience Clyde Biosciences’ scientists work with…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivate